Cellular Flow Design will not validate your diagnosis. It accepts whatever cause you bring from Analyse. If the real problem is upstream data quality, the tool will still produce a neat four cell design, and that design will still fail in pilot. Validation belongs in Measure and Analyse, not here.
It will not balance the line for you. The sample shows takt times of 3, 1, 5 and 6 minutes. The tool reports those figures. It does not tell you how to even them out, how much buffer to hold between cells, or what release rate to use. Those remain engineering judgements.
It will not estimate cost, headcount, savings or payback. There is no financial model behind the worksheet. Any benefit case you build has to come from separate volume and cost data that you gather yourself.
It will not confirm that the resources exist or are available. Naming an OCR system, a rules engine, an approver with workflow and a payment system is a design statement, not a procurement check. Somebody still has to confirm each one can be dedicated to its cell.
And it will not tell you whether the design is better than the current process. The worksheet holds four rows describing the future state only. The comparison is yours to make. What the tool gives you is a design clear enough to pilot and specific enough to argue about before you spend anything.